MATRIX: MAPPING AUSTRALIAN TREATMENT REALITY INVOLVING METHOTREXATE (MTX), A SURVEY STUDY OF RHEUMATOLOGISTS AND THEIR PATIENTS WITH RHEUMATOID ARTHRITIS (RA)

被引：0
|
作者：
Nash, P.
Nicholls, D. [1 ,2 ]
机构：
[1] Univ Queensland, Dept Med, Brisbane, Qld 4072, Australia
[2] Coast Joint Care, Maroochydore, Qld, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2012年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [31] Alternate therapy with leflunomide (LEF) or methotrexate (MTX) after switch from initial treatment in patients with active rheumatoid arthritis (RA).
    Olsen, N
    Schiff, M
    Strand, V
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S241 - S241
  • [32] Efficacy of FK506 in rheumatoid arthritis (RA): A 6 month, dose-ranging study in RA patients failing methotrexate (MTX).
    Furst, DE
    Sherrer, Y
    Fleischmann, RM
    Block, J
    Rutstein, J
    Stamler, D
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S271 - S271
  • [33] The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): A masked and controlled study
    Ince, A
    Yazici, Y
    Hamuryudan, V
    Yazici, H
    CLINICAL RHEUMATOLOGY, 1996, 15 (05) : 491 - 494
  • [34] Combination of leflunomide (LEF) and methotrexate (MTX) in patients (pts) with active rheumatoid arthritis (RA) failing MTX monotherapy - An open-label extension study
    Kremer, J
    Genovese, M
    Cannon, GW
    Caldwell, J
    Cush, J
    Weisman, M
    Luggen, ME
    Kame, J
    Bensen, W
    Furst, D
    Bathon, J
    Keystone, F
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S144 - S144
  • [35] PROGRESS OF JOINT DESTRUCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING METHOTREXATE (MTX) TREATMENT
    NICKSCH, E
    POTT, HG
    DEGNER, F
    WITTENBORG, A
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1988, 47 (04): : 286 - 286
  • [36] IMPROVED RADIOLOGICAL OUTCOME OF RHEUMATOID ARTHRITIS (RA): EVIDENCE FOR EARLY TREATMENT WITH METHOTREXATE (MTX) AS A KEY PROGNOSTIC FACTOR
    Belke-Voss, E.
    Fiehn, C.
    Krause, D.
    Wassenberg, S.
    Rau, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 837 - 838
  • [37] Guidelines for monitoring methotrexate-treated rheumatoid arthritis (RA) patients: What are rheumatologists doing and is it time for a change?
    Yazici, Y
    Erkan, D
    Paget, SA
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 417 - 417
  • [38] An observational study of the tolerability and efficacy of switching from oral to IM methotrexate (MTX) in patients with documented resistant rheumatoid arthritis (RA)
    Bingham, S. J.
    Buch, M.
    Crystyn, H.
    Aldred, A.
    Wong, I.
    Khu, N.
    Lindsay, S.
    Pollard, A.
    Emery, P.
    RHEUMATOLOGY, 2001, 40 : 35 - 36
  • [39] An observational study of the tolerability and efficacy of leflunomide (LEF) alone and in combination with methotrexate (MTX) in patients with documented resistant rheumatoid arthritis (RA)
    Bingham, Sarah J.
    Buch, Maya
    Lindsay, Stephanie
    Pollard, Alan
    Emery, Paul
    RHEUMATOLOGY, 2001, 40 : 33 - 34
  • [40] THE EFFECT OF SUBCUTANEOUS (SC) METHOTREXATE (MTX) AND ADALIMUMAB (ADA) ON CYTOKINE PROFILE IN MTX-NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (RA)
    Avdeeva, A. S.
    Novikov, A. A.
    Aleksandrova, E. N.
    Karateev, D. E.
    Luchihina, E. L.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 215 - 216
12345